| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |